NCT00831129View on ClinicalTrials.gov

A Study for Pre-diabetic Patients With Cholesterol Lowering Drugs

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Pre-diabetes
Interventions
DRUG

Rosiglitazone

4 mg daily

DRUG

Placebo Rosiglitazone

1 tab daily

DRUG

Simvastatin

40 mg daily

Trial Locations (1)

60637

University of Chicago, Chicago

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Chicago

OTHER